Insider Trading & Ownership - Session R.A. II

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Session R.A. II
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-07-12
Sale
2023-07-14
4:00 pm
Taysha Gene Therapies Inc.TSHASession R.A. II
10% Owner
85,872$0.70769$60,7719,153,927
(Indirect
Direct)
View
2023-06-22
Sale
2023-06-26
4:46 pm
Taysha Gene Therapies Inc.TSHASession R.A. II
10% Owner
28,608$0.70327$20,1199,239,799
(Indirect
Direct)
View
2023-06-20
Sale
2023-06-22
4:00 pm
Taysha Gene Therapies Inc.TSHASession R.A. II
10% Owner
434,615$0.70831$307,8449,268,407
(Indirect
Direct)
View
2021-11-23
Purchase
2021-12-08
4:05 pm
Taysha Gene Therapies Inc.TSHASession R.A. II
President and CEO
10% Owner
42,518$12.44$529,1029,473,100
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-03-06
Disposition
2023-03-08
7:38 pm
N/A
2032-11-10
Taysha Gene Therapies Inc.TSHASession R.A. II
10% Owner
199,500$09,954,318
(Direct)
View
2023-03-06
Other
2023-03-08
7:38 pm
N/A
N/A
Taysha Gene Therapies Inc.TSHASession R.A. II
10% Owner
251,296$09,954,318
(Direct)
View
2022-11-10
Option Award
2022-12-23
4:15 pm
N/A
2032-11-10
Taysha Gene Therapies Inc.TSHASession R.A. II
Director
10% Owner
199,500$0199,500
(Direct)
View
2022-02-23
Option Award
2022-02-25
4:17 pm
N/A
2032-02-23
Taysha Gene Therapies Inc.TSHASession R.A. II
President and CEO
10% Owner
217,850$0217,850
(Direct)
View
2021-01-19
Option Award
2021-01-20
8:22 pm
N/A
2031-01-19
Taysha Gene Therapies Inc.TSHASession R.A. II
President and CEO
10% Owner
199,700$0199,700
(Direct)
View

Ownership
2020-09-23
8:32 pm
N/A
N/A
Taysha Gene Therapies Inc.TSHASession R.A. II
President and CEO
10% Owner
0$09,430,582
(Direct)
View

Ownership
2020-04-27
1:42 pm
N/A
N/A
Chardan Healthcare Acquisition 2 Corp.CHAQSession R.A. II
Director
0$010,000
(Direct)
View